CIPLA
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Cipla along with daily highs, lows, percentage changes and volume trends, and, all financial information.
3.24₹ 49
As on Oct 10, 2025, 4:01 PM IST
Cipla Price Performance
Today's LowToday's High
₹1,508.00₹1,568.95
₹1,561.55
52 Weeks' Low52 Weeks' High
₹1,310.05₹1,694.95
₹1,561.55
Open Price
₹1,514.00
Prev. Close
₹1,512.55
Volume
61,002
Over the last 5 years, the share price of Cipla has gained 13.90% CAGR. Over the past year, the corresponding return has been -3.52%.
Cipla’s current P/E of 23.39x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Cipla Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cipla | 3.03 | -0.14 | 5.70 | 6.73 | -3.52 | 11.74 | 13.90 |
| Sun Pharmaceutical Industries | 2.25 | 4.84 | 0.46 | -0.99 | -11.47 | 20.88 | 26.60 |
| Divi's Laboratories | 10.42 | 7.43 | -5.31 | 15.83 | 9.05 | 20.72 | 15.21 |
| Torrent Pharmaceuticals | 0.66 | -1.56 | 5.93 | 13.10 | 2.70 | 30.43 | 20.03 |
| Dr. Reddy's Laboratories | 1.34 | -3.02 | 0.44 | 14.03 | -3.93 | 13.02 | 3.91 |
| Mankind Pharma | 0.32 | -5.82 | -3.40 | 4.50 | -8.25 | 19.94 | 11.53 |
| Zydus Lifesciences | 0.48 | -4.42 | 2.03 | 14.42 | -6.01 | 32.72 | 17.63 |
| Lupin | -0.52 | -0.80 | 3.48 | -0.37 | -8.97 | 40.55 | 13.37 |
| Aurobindo Pharma | 3.33 | 7.58 | 0.05 | 4.38 | -22.88 | 28.28 | 6.23 |
| Alkem Laboratories | 0.55 | 2.70 | 15.42 | 11.97 | -10.95 | 19.79 | 15.09 |
| Abbott India | 1.02 | -3.34 | -12.60 | 2.27 | 6.61 | 17.17 | 13.41 |
| Glenmark Pharmaceuticals | -2.21 | -9.21 | 1.57 | 40.47 | 9.96 | 70.05 | 31.32 |
| Laurus Labs | 1.20 | -2.21 | 10.52 | 44.67 | 88.45 | 19.29 | 21.45 |
| Biocon | 0.23 | -3.04 | -5.24 | 11.48 | 2.07 | 8.35 | -5.27 |
| GlaxoSmithKline Pharmaceuticals | 1.46 | -2.07 | -14.62 | 1.02 | 0.56 | 25.83 | 11.82 |
| Anthem Biosciences | 5.39 | -1.88 | 9.56 | 9.56 | 9.56 | 3.09 | 1.84 |
| Cohance Lifesciences | 3.46 | -8.69 | -9.22 | -21.38 | -23.96 | 29.11 | 19.99 |
| Ipca Laboratories | 1.57 | 1.49 | -7.56 | 0.14 | -16.26 | 13.47 | 4.76 |
| Gland Pharma | -1.58 | 0.97 | 4.30 | 37.81 | 13.01 | -2.14 | 1.09 |
| Ajanta Pharma | 1.02 | -6.43 | -6.23 | -5.44 | -27.34 | 24.18 | 18.52 |
Over the last one year, Cipla has declined 3.52% compared to peers like Sun Pharmaceutical Industries (-11.47%), Divi's Laboratories (9.05%), Torrent Pharmaceuticals (2.70%). From a 5 year perspective, Cipla has outperformed peers relative to Sun Pharmaceutical Industries (26.60%) and Divi's Laboratories (15.21%).
Cipla Financials
Cipla Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,510.35 | 1,506.82 |
| 10 | 1,508.85 | 1,513.84 |
| 20 | 1,533.79 | 1,526.19 |
| 50 | 1,544.35 | 1,532.4 |
| 100 | 1,518.05 | 1,523.41 |
| 200 | 1,496.69 | 1,508.6 |
Cipla Share Holding Pattern
In the latest quarter, Cipla saw a drop in promoter holding to 29.18%, while DII stake increased to 29.25%, FII holding fell to 25.24%, and public shareholding moved down to 16.31% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Cipla Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Flexi Cap Fund - Regular Plan | 2,10,00,000 | 4.07 | 3,337.74 |
| SBI Nifty 50 ETF | 1,01,44,567 | 0.81 | 1,612.38 |
| SBI Long Term Equity Fund | 60,98,542 | 3.24 | 969.3 |
| HDFC Focused 30 Fund - Regular Plan | 60,00,000 | 4.25 | 953.64 |
| HDFC ELSS Tax Saver Fund | 54,00,000 | 5.19 | 858.28 |
| SBI Contra Fund | 38,36,985 | 1.31 | 609.85 |
| Kotak Flexicap Fund - Regular Plan | 35,50,000 | 1.05 | 564.24 |
| Franklin India Focused Equity Fund | 35,00,000 | 4.54 | 556.29 |
| Nippon India Pharma Fund | 32,00,000 | 6.09 | 508.61 |
| UTI Nifty 50 ETF | 31,80,569 | 0.81 | 505.52 |
Cipla Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Cipla Options
Cipla Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 24, 2025, 10:12 PM IST | Cipla - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday, 30Th October, 2 |
| Sep 13, 2025, 12:21 AM IST | Cipla - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Sep 12, 2025, 10:10 PM IST | Cipla - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) R |
| Sep 11, 2025, 12:45 AM IST | Cipla - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 27, 2025, 1:49 AM IST | Cipla - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
About Cipla
Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 19044.85 Cr. and Equity Capital is Rs. 161.52 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressCipla House, Peninsula Business Park, Mumbai Maharashtra 400013
- Contact
Management
- Dr. Y K HamiedChairman
- Mr. Umang VohraManaging Director & Global CEO
- Mr. Kamil HamiedNon Exe.Non Ind.Director
- Mr. Abhijit JoshiNon Exe.Non Ind.Director
- Mr. Adil ZainulbhaiNon Exe.Non Ind.Director
- Dr. Balram BhargavaIndependent Director
- Dr. Mandar VaidyaIndependent Director
- Ms. Maya HariIndependent Director
- Mr. P R RameshIndependent Director
- Mr. Robert StewartIndependent Director
- Ms. Sharmila ParanjpeIndependent Director
FAQs on Cipla Share Price
What is the share price of Cipla?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cipla is ₹1,561.55 as on Oct 10, 2025.
What kind of stock is Cipla?
The Cipla is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Cipla?
The market cap of Cipla is ₹126,136.65 Cr as on Oct 10, 2025.
What are today's High and Low prices of Cipla?
Today’s highest and lowest price of Cipla are ₹1,568.95 and ₹1,508.00.
What are the 52 Week High and 52 Week Low of Cipla?
The 52-week high/low is the highest and lowest price at which Cipla stock has traded in the past 52-week or nearly a year. The 52-week high of Cipla is ₹1,694.95 and 52-week low of Cipla is ₹1,310.05 as on Oct 10, 2025.
How has the Cipla performed historically in terms of returns?
The Cipla has shown returns of 3.24% over the past day, -0.14% for the past month, 5.7% over 3 months, -3.52% over 1 year, 11.74% across 3 years, and 13.9% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Cipla?
P/E ratio of and PB ratio of Cipla are 23.39 and 4.45 on Oct 10, 2025. While the company gives a dividend yield of 1.02 per annum.
Trending In Market
Mutual Funds Screener
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data